← Back to catalogue

Sodium Chloride Solution USP 7%

FDA UDI

Class II (US FDA UDI)

by Pharmacaribe Llc

Identity

Trade Name
Sodium Chloride Solution USP 7% FDA UDI
Generic Name
Inhalation therapy saline solution, hypertonic FDA UDI
Device Name
Carton with 60 vials: 7% Sodium Chloride Inhalation Solution, made to USP, 4mL vial, sterile, preservative-free,non-pyrogenic FDA UDI
Model / Reference
14123 FDA UDI
Description
Carton with 60 vials: 7% Sodium Chloride Inhalation Solution, made to USP, 4mL vial, sterile, preservative-free,non-pyrogenic FDA UDI

Identifiers

Catalog Number
50190-141-23 FDA UDI
Primary DI / UDI-DI
40850877007026 FDA UDI
510(k) Number
K101424 FDA UDI
FDA Product Code
CAF FDA UDI
GMDN Term
Inhalation therapy saline solution, hypertonic FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
868.5630 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

Yes

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Dimensions & Sizes

Size
Total Volume — 4 Milliliter FDA UDI

Category: Inhalation therapy saline solution, hypertonic

Sodium Chloride Solution USP 7% by Pharmacaribe Llc — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Inhalation therapy saline solution, hypertonic.

Cleared under the same submission

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Pharmacaribe Llc

Sources (1)

  • FDA UDI cc96dc2c-dcbf-4587-89ef-7dcf864bfb02 38 fields · synced May 30, 2026